Wu et al. suggest that CD248 (endosialin) is a specific biomarker for NSCLC-derived CAFs, which promotes metastasis by triggering ECM stiffness via activation of the Hippo signaling pathway. Here, CD248 is linked to non-small cell lung carcinoma.